Back to search results

The ABC-HCC Trial: Atezolizumab Plus Bevacizumab vs. Transarterial Chemoembolization (TACE) in Intermediate-stage HepatoCellular Carcinoma

Abroad (travel likely)RecruitingPHASE3

Conditions

Hepatocellular Carcinoma

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • LKH - Univ. Klinikum Graz, Graz, Austria

  • Medzinische Universität Innsbruck, Innsbruck, Austria

  • Klinikum Klagenfurt am Wörthersee, Klagenfurt, Austria

  • Ordensklinikum Linz, Linz, Austria

  • Universitätsklinikum St. Pölten, Sankt Pölten, Austria

  • Medizinische Universität Wien, Vienna, Austria

  • Institut Sainte-Catherine, Avignon, France

  • Hôpital Jean-Verdier Avicenne, Bobigny, France

  • CHU Bordeaux, Bordeaux, France

  • CHU Clermont-Ferrand CHU Estaing, Clermont-Ferrand, France

  • Beaujon Hospital, Clichy, France

  • CHU Grenoble, Grenoble, France

  • Croix-Rousse Hopital, Lyon, France

  • Saint Joseph Hopital - Marseille, Marseille, France

  • Hôpital Universitaire Pitié Salpêtrière, Paris, France

  • Centre Hépato-biliaire Paul Brousse, Villejuif, France

  • University Hospital RWTH Aachen, Aachen, Germany

  • Klinikum St. Marien Amberg, Amberg, Germany

  • Vivantes Klinikum Neukölln, Berlin, Germany

  • Universitätsklinikum Bochum, Bochum, Germany

  • Uniklinik Köln, Cologne, Germany

  • Universitätsklinikum Dresden, Dresden, Germany

  • Universitätsklinikum Düsseldorf, Düsseldorf, Germany

  • Universitätsklinikum Erlangen, Erlangen, Germany

  • Klinikum Esslingen, Esslingen am Neckar, Germany

  • Universitätsklinikum Frankfurt, Frankfurt, Germany

  • Krankenhaus Nordwest, Frankfurt am Main, Germany

  • Universitätsklinikum Freiburg, Freiburg im Breisgau, Germany

  • Universitätsmedizin Göttingen, Göttingen, Germany

  • Medizinische Hochschule Hannover, Hanover, Germany

  • Klinikum Konstanz, Konstanz, Germany

  • Krankenhaus Maria-Hilf Krefeld, Krefeld, Germany

  • Universitätsklinikum Schleswig-Holstein, Lübeck, Germany

  • Universitätsmedizin Mainz, Mainz, Germany

    Contact: Study coordinator (Peter Galle, Prof. Dr.) · peter.galle@unimedizin-mainz.de · 00496131177275
    Contact: Principal Investigator (Peter Galle, Prof. Dr.)

  • Universitätsklinikum Mannheim, Mannheim, Germany

  • Universitätsklinikum Marburg, Marburg, Germany

  • Klinikum rechts der Isar München, München, Germany

  • Klinikum Mutterhaus Trier, Trier, Germany

  • Krankenhaus der Barmherzigen Brüder Trier, Trier, Germany

  • Uniklinik Ulm, Ulm, Germany

  • St. Josefs Hospital Wiesbaden, Wiesbaden, Germany

  • Universitätsklinikum Würzburg, Würzburg, Germany

  • Policlinico S. Orsola Bologna, Bologna, Italy

  • Instituto Tumori della Romagna IRST IRCCS, Meldola, Italy

  • Policlinico di Milano, Milan, Italy

  • Instituto di Tumori, Milan, Italy

  • Università di Pisa (UNIPI), Pisa, Italy

  • AOUI Verona, Verona, Italy

  • Hokkaido University Hospital, Hokkaido, Japan

  • Kobe University Hospital, Kobe, Japan

  • Kumamoto University Hospital, Kumamoto, Japan

  • University Hospital Kyoto Prefectural University of Medicine, Kyoto, Japan

  • Nagasaki University Hospital, Nagasaki, Japan

  • Kindai University Hospital, Osaka, Japan

  • Saitama Medical University Hospital, Saitama, Japan

  • Fujita Health University Hospital, Toyoake, Japan

  • Yamaguchi University Hospital, Ube, Japan

  • Hospital Universitario de Alicante, Alicante, Spain

  • Hospital Infanta Cristina, Badajoz, Spain

  • Hospital Germans Trias I Pujol, Badalona, Spain

  • Hospital Universitari Vall d'Hebrón, Barcelona, Spain

  • Barcelona Clinic Liver Cancer, Universitat de Bracelona, Barcelona, Spain

    Contact: Study coordinator (Jordi Bruix, Prof. Dr.) · jbruix@clinic.cat

  • Hospital Puerta del Mar, Cadiz, Spain

  • Hospital de Jaen, Jaén, Spain

  • Hospital Universitario Gregorio Marañon, Madrid, Spain

  • Hospital Universitario Ramón y Cajal, Madrid, Spain

  • Hospital Fundación Jimenez Diaz, Madrid, Spain

  • Hospital Universitario Puerta de Hierro Majadahonda, Madrid, Spain

  • Hospital de Alcorcón, Madrid, Spain

  • Hospital de Málaga, Málaga, Spain

  • Hospital Marqués de Valdecilla, Santander, Spain

  • Hospital Universitario Virgen del Rocío, Seville, Spain

Study leads

  • Salah Eddin Al-Batran, Prof. Dr.

    Study Director

    Institut für Klinische Krebsforschung IKF GmbH, Frankfurt, Germany

  • Peter Galle, Prof. Dr.

    Principal Investigator

    Universitätsmedizin Mainz, Germany

  • Jordi Bruix, Prof. Dr.

    Principal Investigator

    Barcelona Clinic Liver Cancer, Universitat de Barcelona, Spain

View source on ClinicalTrials.gov(opens in a new tab)Contact study team (email)